English
Insider transactions
EDGAROpus Genetics, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-22.
- Open-market purchases (code P)
- 2 transactions, 164,000 shares
- Sum of shares × price per share: 323,693.4
- Open-market sales (code S)
- 24 transactions, 6,476,531 shares
- Sum of shares × price per share: 19,675,663.32
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–50 of 53
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-03 Filed 2026-11-05 | Magrath George Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 28,258 | 3.8992 | 110,183.5936Derived: shares × price per share. Exact value 110183.5936. | 2,010,636 | Direct (D) | No | F1, F2
| Open filing 0001140361-26-042102 Read from the filing’s XML Dispute this row |
| 2026-10-23 Filed 2026-10-27 | Magrath George Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 9,591 | 3.585 | 34,383.735Derived: shares × price per share. Exact value 34383.735. | 2,038,894 | Direct (D) | No | F1
| Open filing 0001140361-26-040893 Read from the filing’s XML Dispute this row |
| 2026-10-23 Filed 2026-10-27 | SCHACHLE JOSEPH K Officer: Chief Operating Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,767 | 3.565 | 16,994.355Derived: shares × price per share. Exact value 16994.355. | 286,673 | Direct (D) | No | F1
| Open filing 0001140361-26-040908 Read from the filing’s XML Dispute this row |
| 2026-10-23 Filed 2026-10-27 | YERXA BENJAMIN R Director · Officer: President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,669 | 3.5514 | 27,235.6866Derived: shares × price per share. Exact value 27235.6866. | 696,437 | Direct (D) | No | F1, F2
| Open filing 0001140361-26-040906 Read from the filing’s XML Dispute this row |
| 2026-10-23 Filed 2026-10-27 | YERXA BENJAMIN R Director · Officer: President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 25,520 | 3.5317 | 90,128.984Derived: shares × price per share. Exact value 90128.9840. | 670,917 | Direct (D) | No | F1, F3
| Open filing 0001140361-26-040906 Read from the filing’s XML Dispute this row |
| 2026-10-23 Filed 2026-10-27 | Gagnon Robert E. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 14,000 | 3.5464 | 49,649.6Derived: shares × price per share. Exact value 49649.6000. | 542,375 | Direct (D) | Yes | F1, F2
| Open filing 0001140361-26-040896 Read from the filing’s XML Dispute this row |
| 2026-09-30 Filed 2026-10-02 | Foundation Fighting Blindness Retinal Degeneration Fund Director · Other: See RemarksFoundation Fighting Blindness, Inc. Director · Other: See Remarks | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 556,000 | 4.9568 | 2,755,980.8Derived: shares × price per share. Exact value 2755980.8000. | 3,236,171 | Direct (D) | No | F1, F2
| Open filing 0002042266-26-000002 Read from the filing’s XML Dispute this row |
| 2026-09-09 Filed 2026-09-11 | Magrath George Director · Officer: Chief Executive Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 392,157 | 1.15 | 450,980.55Derived: shares × price per share. Exact value 450980.55. | 2,124,026 | Direct (D) | No | — | Open filing 0001140361-26-036347 Read from the filing’s XML Dispute this row |
| 2026-09-09 Filed 2026-09-11 | Magrath George Director · Officer: Chief Executive Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 75,541 | 5.97 | 450,979.77Derived: shares × price per share. Exact value 450979.77. | 2,048,485 | Direct (D) | No | F1
| Open filing 0001140361-26-036347 Read from the filing’s XML Dispute this row |
| 2026-09-09 Filed 2026-09-11 | Magrath George Director · Officer: Chief Executive Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 392,157 | 0 | — | 0 | Direct (D) | No | F2
| Open filing 0001140361-26-036347 Read from the filing’s XML Dispute this row |
| 2026-09-08 Filed 2026-09-08 | Gallagher Cam Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 784,314 | 1.15 | 901,961.1Derived: shares × price per share. Exact value 901961.10. | 2,800,111 | Direct (D) | No | F1
| Open filing 0001140361-26-035913 Read from the filing’s XML Dispute this row |
| 2026-09-08 Filed 2026-09-08 | Gallagher Cam Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 784,314 | 0 | — | 0 | Direct (D) | No | F3
| Open filing 0001140361-26-035913 Read from the filing’s XML Dispute this row |
| 2026-09-03 Filed 2026-09-08 | Gagnon Robert E. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 28,000 | 4.5433 | 127,212.4Derived: shares × price per share. Exact value 127212.4000. | 556,375 | Direct (D) | No | F1, F2
| Open filing 0001140361-26-035912 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | Magrath George Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 9,475 | 2.9473 | 27,925.6675Derived: shares × price per share. Exact value 27925.6675. | 1,731,869 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-003352 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | Gagnon Robert E. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,783 | 2.9477 | 22,941.9491Derived: shares × price per share. Exact value 22941.9491. | 584,375 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-003351 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | YERXA BENJAMIN R Director · Officer: President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,429 | 2.97 | 22,064.13Derived: shares × price per share. Exact value 22064.13. | 704,106 | Direct (D) | No | F1
| Open filing 0000905148-26-003354 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | SCHACHLE JOSEPH K Officer: Chief Operating Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,644 | 2.94 | 13,653.36Derived: shares × price per share. Exact value 13653.36. | 291,440 | Direct (D) | No | F1
| Open filing 0000905148-26-003353 Read from the filing’s XML Dispute this row |
| 2026-05-18 Filed 2026-05-20 | Foundation Fighting Blindness Retinal Degeneration Fund Director · Other: See RemarksFoundation Fighting Blindness, Inc. Director · Other: See Remarks | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,700,000 | 4.35 | 7,395,000Derived: shares × price per share. Exact value 7395000.00. | 3,792,171 | Direct (D) | No | F1
| Open filing 0002042266-26-000001 Read from the filing’s XML Dispute this row |
| 2026-04-23 Filed 2026-04-27 | Zaremba Rabourn Amy Officer: Head of Fin. Quality Assurance | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,641 | 5.204 | 8,539.764Derived: shares × price per share. Exact value 8539.764. | 188,671 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-001865 Read from the filing’s XML Dispute this row |
| 2026-04-23 Filed 2026-04-27 | Magrath George Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 9,511 | 5.22 | 49,647.42Derived: shares × price per share. Exact value 49647.42. | 1,741,344 | Direct (D) | No | F1
| Open filing 0000905148-26-001864 Read from the filing’s XML Dispute this row |
| 2026-04-23 Filed 2026-04-27 | Gagnon Robert E. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,842 | 5.1846 | 40,657.6332Derived: shares × price per share. Exact value 40657.6332. | 592,158 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-001862 Read from the filing’s XML Dispute this row |
| 2026-04-23 Filed 2026-04-27 | YERXA BENJAMIN R Director · Officer: President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,470 | 5.2371 | 39,121.137Derived: shares × price per share. Exact value 39121.1370. | 711,535 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-001867 Read from the filing’s XML Dispute this row |
| 2026-04-23 Filed 2026-04-27 | SCHACHLE JOSEPH K Officer: Chief Operating Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,697 | 5.2202 | 24,519.2794Derived: shares × price per share. Exact value 24519.2794. | 296,084 | Direct (D) | No | F1
| Open filing 0000905148-26-001866 Read from the filing’s XML Dispute this row |
| 2026-04-23 Filed 2026-04-27 | Jayagopal Ashwath Officer: Chief Scientific Dev. Ofc. | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,542 | 5.1917 | 39,155.8014Derived: shares × price per share. Exact value 39155.8014. | 509,233 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-001863 Read from the filing’s XML Dispute this row |
| 2026-04-20 Filed 2026-04-22 | Graves Adrienne L Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,367 | 0 | — | 127,514 | Direct (D) | No | F1
| Open filing 0000905148-26-001786 Read from the filing’s XML Dispute this row |
| 2026-04-20 Filed 2026-04-22 | Bennett Jean Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,367 | 0 | — | 259,019 | Direct (D) | No | F1
| Open filing 0000905148-26-001782 Read from the filing’s XML Dispute this row |
| 2026-04-20 Filed 2026-04-22 | Rodgers Richard J Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,367 | 0 | — | 343,022 | Direct (D) | No | F1
| Open filing 0000905148-26-001788 Read from the filing’s XML Dispute this row |
| 2026-04-20 Filed 2026-04-22 | Gallagher Cam Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,367 | 0 | — | 2,015,797 | Direct (D) | No | F1
| Open filing 0000905148-26-001785 Read from the filing’s XML Dispute this row |
| 2026-04-20 Filed 2026-04-22 | MANUSO JAMES S J Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,367 | 0 | — | 317,318 | Direct (D) | No | F1
| Open filing 0000905148-26-001787 Read from the filing’s XML Dispute this row |
| 2026-04-20 Filed 2026-04-22 | Benton Susan Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,367 | 0 | — | 243,894 | Direct (D) | No | F1
| Open filing 0000905148-26-001784 Read from the filing’s XML Dispute this row |
| 2026-04-20 Filed 2026-04-22 | Ainsworth Sean Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,367 | 0 | — | 321,692 | Direct (D) | No | F1
| Open filing 0000905148-26-001781 Read from the filing’s XML Dispute this row |
| 2026-03-16 Filed 2026-03-18 | Magrath George Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 24,438 | 5.2102 | 127,326.8676Derived: shares × price per share. Exact value 127326.8676. | 1,750,855 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-001381 Read from the filing’s XML Dispute this row |
| 2026-03-16 Filed 2026-03-18 | Jayagopal Ashwath Officer: Chief Scientific Dev. Ofc. | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,719 | 5.1213 | 19,046.1147Derived: shares × price per share. Exact value 19046.1147. | 516,775 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-001380 Read from the filing’s XML Dispute this row |
| 2026-03-16 Filed 2026-03-18 | Zaremba Rabourn Amy Officer: Head of Fin. Quality Assurance | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,816 | 5.245 | 14,769.92Derived: shares × price per share. Exact value 14769.920. | 190,312 | Direct (D) | No | F1
| Open filing 0000905148-26-001382 Read from the filing’s XML Dispute this row |
| 2026-03-16 Filed 2026-03-18 | SCHACHLE JOSEPH K Officer: Chief Operating Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,719 | 5.2501 | 19,525.1219Derived: shares × price per share. Exact value 19525.1219. | 300,781 | Direct (D) | No | F1
| Open filing 0000905148-26-001384 Read from the filing’s XML Dispute this row |
| 2026-02-12 Filed 2026-02-17 | Jayagopal Ashwath Officer: Chief Scientific Dev. Ofc. | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 5,313 | 3.39 | 18,011.07Derived: shares × price per share. Exact value 18011.07. | 520,494 | Direct (D) | No | F1
| Open filing 0000905148-26-000904 Read from the filing’s XML Dispute this row |
| 2026-01-22 Filed 2026-01-26 | Gagnon Robert E. Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 400,000 | 0 | — | 600,000 | Direct (D) | No | F1
| Open filing 0000905148-26-000354 Read from the filing’s XML Dispute this row |
| 2026-01-22 Filed 2026-01-26 | YERXA BENJAMIN R Director · Officer: President | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 400,000 | 0 | — | 719,005 | Direct (D) | No | F1
| Open filing 0000905148-26-000359 Read from the filing’s XML Dispute this row |
| 2026-01-22 Filed 2026-01-26 | Jayagopal Ashwath Officer: Chief Scientific Dev. Ofc. | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 400,000 | 0 | — | 525,807 | Direct (D) | No | F1
| Open filing 0000905148-26-000355 Read from the filing’s XML Dispute this row |
| 2026-01-22 Filed 2026-01-26 | SCHACHLE JOSEPH K Officer: Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 250,000 | 0 | — | 304,500 | Direct (D) | No | F1
| Open filing 0000905148-26-000358 Read from the filing’s XML Dispute this row |
| 2026-01-22 Filed 2026-01-26 | Zaremba Rabourn Amy Officer: Head of Fin. Quality Assurance | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 86,500 | 0 | — | 193,128 | Direct (D) | No | F1
| Open filing 0000905148-26-000357 Read from the filing’s XML Dispute this row |
| 2026-01-22 Filed 2026-01-26 | Magrath George Director · Officer: Chief Executive Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 483,639 | 0 | — | 1,775,293 | Direct (D) | No | F1
| Open filing 0000905148-26-000356 Read from the filing’s XML Dispute this row |
| 2026-01-18 Filed 2026-01-21 | Zaremba Rabourn Amy Officer: Head of Fin. Quality Assurance | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 3,390 | 2.1 | 7,119Derived: shares × price per share. Exact value 7119.0. | 106,628 | Direct (D) | No | F1
| Open filing 0000905148-26-000282 Read from the filing’s XML Dispute this row |
| 2026-01-10 Filed 2026-01-13 | Zaremba Rabourn Amy Officer: Head of Fin. Quality Assurance | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 3,950 | 1.93 | 7,623.5Derived: shares × price per share. Exact value 7623.50. | 110,018 | Direct (D) | No | F1
| Open filing 0000905148-26-000164 Read from the filing’s XML Dispute this row |
| 2026-01-06 Filed 2026-01-08 | Gallagher Cam Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 67,000 | 0 | — | 1,991,430 | Direct (D) | No | F1
| Open filing 0000905148-26-000088 Read from the filing’s XML Dispute this row |
| 2026-01-01 Filed 2026-01-05 | Bennett Jean Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 21,127 | — | — | 234,652 | Direct (D) | No | F1
| Open filing 0000905148-26-000028 Read from the filing’s XML Dispute this row |
| 2026-01-01 Filed 2026-01-05 | Ainsworth Sean Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 42,507 | — | — | 297,325 | Direct (D) | No | F1
| Open filing 0000905148-26-000027 Read from the filing’s XML Dispute this row |
| 2026-01-01 Filed 2026-01-05 | MANUSO JAMES S J Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 31,188 | — | — | 292,951 | Direct (D) | No | F1
| Open filing 0000905148-26-000036 Read from the filing’s XML Dispute this row |
| 2026-01-01 Filed 2026-01-05 | Graves Adrienne L Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 23,643 | — | — | 103,147 | Direct (D) | No | F1
| Open filing 0000905148-26-000031 Read from the filing’s XML Dispute this row |
| 2025-12-31 Filed 2025-12-31 | Gallagher Cam Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 33,000 | 0 | — | 1,924,430 | Direct (D) | No | F4, F5
| Open filing 0000905148-25-004511 Read from the filing’s XML Dispute this row |
Latest reported holdings
What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.
| Reporting owner | Security | Shares owned after | Direct or indirect | Source |
|---|---|---|---|---|
| Ainsworth Sean Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 79,592 | D | As of 2025-04-30 Open filing 4 |
| Ainsworth Sean Director | Common Stock | 321,692 | D | As of 2026-04-20 Open filing 4 |
| Bennett Jean Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 79,592 | D | As of 2025-04-30 Open filing 4 |
| Bennett Jean Director | Common Stock | 259,019 | D | As of 2026-04-20 Open filing 4 |
| Benton Susan Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 79,592 | D | As of 2025-04-30 Open filing 4 |
| Benton Susan Director | Common Stock | 243,894 | D | As of 2026-04-20 Open filing 4 |
| Foundation Fighting Blindness Retinal Degeneration Fund Director · 10% owner · Other: See Remarks | Series A Non-Voting Convertible Preferred Stock Derivative security · underlying Common Stock | 0 | D | As of 2025-05-05 Open filing 4 |
| Foundation Fighting Blindness Retinal Degeneration Fund Director · Other: See Remarks | Common Stock | 3,236,171 | D | As of 2026-09-30 Open filing 4 |
| Foundation Fighting Blindness, Inc. Director · 10% owner · Other: See Remarks | Series A Non-Voting Convertible Preferred Stock Derivative security · underlying Common Stock | 0 | D | As of 2025-05-05 Open filing 4 |
| Foundation Fighting Blindness, Inc. Director · Other: See Remarks | Common Stock | 3,236,171 | D | As of 2026-09-30 Open filing 4 |
| Gagnon Robert E. Officer: Chief Financial Officer | Employee Stock Option (right to buy) Derivative security · underlying Common Stock | 250,000 | D | As of 2025-09-02 Open filing 4 |
| Gagnon Robert E. Officer: Chief Financial Officer | Common Stock | 542,375 | D | As of 2026-10-23 Open filing 4 |
| Gallagher Cam Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 79,592 | D | As of 2025-04-30 Open filing 4 |
| Gallagher Cam Director | Warrant (right to buy) Derivative security · underlying Common Stock | 0 | D | As of 2026-09-08 Open filing 4 |
| Gallagher Cam Director | Warrants (right to buy) Derivative security · underlying Common Stock | 784,314 | D | As of 2025-03-24 Open filing 4 |
| Gallagher Cam Director | Common Stock | 83,000 | I By Garret Gallagher - Custodian UTMA/UGMA | As of 2026-09-08 Open filing 4 |
| Gallagher Cam Director | Common Stock | 2,800,111 | D | As of 2026-09-08 Open filing 4 |
| Gallagher Cam Director | Common Stock | 83,000 | I By Garret Gallagher - Custodian UTMA/UGMA | As of 2025-12-29 Open filing 4 |
| Graves Adrienne L Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 79,592 | D | As of 2025-04-30 Open filing 4 |
| Graves Adrienne L Director | Common Stock | 127,514 | D | As of 2026-04-20 Open filing 4 |
| Hoffmann Bernhard Officer: SVP of Corp. Dev. | Employee Stock Option (right to buy) Derivative security · underlying Common Stock | 29,500 | D | As of 2025-03-13 Open filing 4 |
| Hoffmann Bernhard Officer: SVP of Corp. Dev. | Common Stock | 185,446 | D | As of 2025-03-13 Open filing 4 |
| Jayagopal Ashwath Officer: Chief Scientific Dev. Ofc. | Employee Stock Option (right to buy) Derivative security · underlying Common Stock | 52,500 | D | As of 2025-03-13 Open filing 4 |
| Jayagopal Ashwath Officer: Chief Scientific Dev. Ofc. | Common Stock | 509,233 | D | As of 2026-04-23 Open filing 4 |
| Jhaveri Nirav S. Officer: Chief Financial Officer | Employee Stock Option (right to buy) Derivative security · underlying Common Stock | 52,500 | D | As of 2025-03-13 Open filing 4 |
| Jhaveri Nirav S. Officer: Chief Financial Officer | Common Stock | 194,293 | D | As of 2025-03-13 Open filing 4 |
| MANUSO JAMES S J Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 79,592 | D | As of 2025-04-30 Open filing 4 |
| MANUSO JAMES S J Director | Common Stock | 317,318 | D | As of 2026-04-20 Open filing 4 |
| Magrath George Officer: Chief Executive Officer | Employee Stock Option (right to buy) Derivative security · underlying Common Stock | 330,697 | D | As of 2025-03-13 Open filing 4 |
| Magrath George Director · Officer: Chief Executive Officer | Warrant (right to buy) Derivative security · underlying Common Stock | 0 | D | As of 2026-09-09 Open filing 4 |
| Magrath George Director · Officer: Chief Executive Officer | Warrants (right to buy) Derivative security · underlying Common Stock | 392,157 | D | As of 2025-03-24 Open filing 4 |
| Magrath George Director · Officer: Chief Executive Officer | Common Stock | 2,010,636 | D | As of 2026-11-03 Open filing 4 |
| Rodgers Richard J Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 79,592 | D | As of 2025-04-30 Open filing 4 |
| Rodgers Richard J Director | Common Stock | 343,022 | D | As of 2026-04-20 Open filing 4 |
| SCHACHLE JOSEPH K Officer: Chief Operating Officer | Employee Stock Option (right to buy) Derivative security · underlying Common Stock | 52,500 | D | As of 2025-03-13 Open filing 4 |
| SCHACHLE JOSEPH K Officer: Chief Operating Officer | Common Stock | 286,673 | D | As of 2026-10-23 Open filing 4 |
| YERXA BENJAMIN R Director · Officer: President | Common Stock | 670,917 | D | As of 2026-10-23 Open filing 4 |
| Zaremba Rabourn Amy Officer: SVP of Finance | Employee Stock Option (right to buy) Derivative security · underlying Common Stock | 39,500 | D | As of 2025-03-13 Open filing 4 |
| Zaremba Rabourn Amy Officer: Head of Fin. Quality Assurance | Common Stock | 188,671 | D | As of 2026-04-23 Open filing 4 |
Joint filers each report the same shares, so rows are not added together.
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.
Showing 1–50 of 123
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 9,000,000 SH | 43,560,000 dollars | Not in the prior quarter’s filings read | Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row |
| Caligan Partners LP | 5,960,972 SH | 28,851,104 dollars | Lower by 116,112 Prior quarter: 6,077,084 | Open filing 0001420506-26-002879 Filed 2026-11-16 Dispute this row |
| Cormorant Asset Management, LP Partly reported under another manager | 5,500,000 SH | 26,620,000 dollars | Not in the prior quarter’s filings read | Open filing 0001583977-26-000011 Filed 2026-11-16 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 5,236,178 SH | 25,343,101 dollars | Higher by 2,119,691 Prior quarter: 3,116,487 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| Nantahala Capital Management, LLC | 4,569,528 SH | 22,116,516 dollars | Lower by 1,553,190 Prior quarter: 6,122,718 | Open filing 0001104659-26-127125 Filed 2026-11-13 Dispute this row |
| Boxer Capital Management, LLC | 4,533,660 SH | 21,942,914 dollars | Higher by 1,718,660 Prior quarter: 2,815,000 | Open filing 0001213900-26-120704 Filed 2026-11-16 Dispute this row |
| Balyasny Asset Management L.P. | 3,728,638 SH | 18,046,608 dollars | Higher by 640,772 Prior quarter: 3,087,866 | Open filing 0001193125-26-463223 Filed 2026-11-16 Dispute this row |
| BIOS Capital Management, LP Partly reported under another manager | 3,683,429 SH | 17,827,796 dollars | Unchanged Prior quarter: 3,683,429 | Open filing 0001813845-26-000009 Filed 2026-11-13 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,273,451 SH | 15,843,503 dollars | Higher by 314,768 Prior quarter: 2,958,683 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| MARSHALL WACE, LLP Partly reported under another manager | 3,161,606 SH | 15,302,172 dollars | Higher by 1,215,997 Prior quarter: 1,945,609 | Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row |
| MILLENNIUM MANAGEMENT LLC | 3,136,021 SH | 15,178,342 dollars | Higher by 833,920 Prior quarter: 2,302,101 | Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row |
| Trails Edge Capital Partners, LP | 2,411,657 SH | 11,672,420 dollars | Lower by 332,001 Prior quarter: 2,743,658 | Open filing 0002077247-26-000005 Filed 2026-11-16 Dispute this row |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,254,996 SH | 10,914,181 dollars | Lower by 3,774,779 Prior quarter: 6,029,775 | Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 1,810,968 SH | 8,767,030 dollars | Higher by 443,256 Prior quarter: 1,367,712 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| ADAR1 Capital Management, LLC | 1,783,781 SH | 8,633,500 dollars | Unchanged Prior quarter: 1,783,781 | Open filing 0001940272-26-000033 Filed 2026-11-16 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 1,330,398 SH | 6,439,126 dollars | Higher by 540,262 Prior quarter: 790,136 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| BOOTHBAY FUND MANAGEMENT, LLC | 1,166,787 SH | 5,647,249 dollars | Lower by 22,728 Prior quarter: 1,189,515 | Open filing 0001549230-26-000012 Filed 2026-11-16 Dispute this row |
| AWM Investment Company, Inc. | 1,051,936 SH | 5,091,370 dollars | Higher by 819,346 Prior quarter: 232,590 | Open filing 0001535264-26-000061 Filed 2026-11-13 Dispute this row |
| Logos Global Management LP | 1,000,000 SH | 4,840,000 dollars | Not in the prior quarter’s filings read | Open filing 0001172661-26-005476 Filed 2026-11-19 Dispute this row |
| Blue Owl Capital Holdings LP Partly reported under another manager | 969,605 SH | 4,692,888 dollars | Not in the prior quarter’s filings read | Open filing 0001193125-26-459653 Filed 2026-11-13 Dispute this row |
| Affinity Asset Advisors, LLC | 900,000 SH | 4,356,000 dollars | Not in the prior quarter’s filings read | Open filing 0001011438-26-000687 Filed 2026-11-13 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 877,876 SH | 4,248,920 dollars | Lower by 649,353 Prior quarter: 1,527,229 | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| GREAT POINT PARTNERS LLC Partly reported under another manager | 776,881 SH | 3,760,104 dollars | Lower by 1,193,306 Prior quarter: 1,970,187 | Open filing 0001172661-26-005345 Filed 2026-11-16 Dispute this row |
| Opaleye Management Inc. | 750,000 SH | 3,630,000 dollars | Lower by 375,000 Prior quarter: 1,125,000 | Open filing 0001420506-26-002880 Filed 2026-11-16 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 734,419 SH | 3,554,588 dollars | Higher by 362,469 Prior quarter: 371,950 | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| UBS Group AG Partly reported under another manager | 723,459 SH | 3,501,542 dollars | Higher by 39,564 Prior quarter: 683,895 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| Woodline Partners LP | 661,729 SH | 3,202,768 dollars | Lower by 772,984 Prior quarter: 1,434,713 | Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 560,304 SH | 2,711,871 dollars | Higher by 118,150 Prior quarter: 442,154 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 538,986 SH | 2,608,692 dollars | Higher by 128,611 Prior quarter: 410,375 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| ACUTA CAPITAL PARTNERS, LLC | 514,110 SH | 2,488,292 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-127905 Filed 2026-11-16 Dispute this row |
| CITADEL ADVISORS LLC | 497,481 SH | 2,407,808 dollars | Lower by 168,181 Prior quarter: 665,662 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| Squarepoint Ops LLC Partly reported under another manager | 352,924 SH | 1,708,152 dollars | Higher by 22,141 Prior quarter: 330,783 | Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager | 350,141 SH | 1,694,682 dollars | Higher by 153,244 Prior quarter: 196,897 | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| XTX Topco Ltd Partly reported under another manager | 287,409 SH | 1,391,060 dollars | Higher by 143,314 Prior quarter: 144,095 | Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row |
| Propel Bio Management, LLC Partly reported under another manager | 270,036 SH | 1,306,974 dollars | Not in the prior quarter’s filings read | Open filing 0001829126-26-012373 Filed 2026-11-13 Dispute this row |
| Aureus Asset Management, LLC | 265,729 SH | 1,286,128 dollars | Higher by 207,529 Prior quarter: 58,200 | Open filing 0001398344-26-020036 Filed 2026-11-13 Dispute this row |
| Bleichroeder LP | 236,842 SH | 1,146,315 dollars | Lower by 500,000 Prior quarter: 736,842 | Open filing 0001420506-26-002662 Filed 2026-11-13 Dispute this row |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 204,178 SH | 988,222 dollars | Higher by 39,125 Prior quarter: 165,053 | Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 162,665 SH | 787,298 dollars | Lower by 302,235 Prior quarter: 464,900 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| Bank of New York Mellon Corp Partly reported under another manager | 151,289 SH | 732,240 dollars | Higher by 28,810 Prior quarter: 122,479 | Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row |
| Informed Momentum Co LLC | 145,687 SH | 705,125 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-127619 Filed 2026-11-16 Dispute this row |
| TWO SIGMA INVESTMENTS, LP | 133,632 SH | 646,779 dollars | Lower by 120,330 Prior quarter: 253,962 | Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row |
| FMR LLC Partly reported under another manager | 129,404 SH | 626,315 dollars | Higher by 129,262 Prior quarter: 142 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| Creative Planning | 128,869 SH | 623,726 dollars | Higher by 503 Prior quarter: 128,366 | Open filing 0001540235-26-000006 Filed 2026-11-02 Dispute this row |
| AQR CAPITAL MANAGEMENT LLC Partly reported under another manager | 120,630 SH | 583,849 dollars | Not in the prior quarter’s filings read | Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row |
| Texas Capital Bank Wealth Management Services Inc | 117,000 SH | 566,280 dollars | Lower by 5,529 Prior quarter: 122,529 | Open filing 0001802655-26-000009 Filed 2026-11-09 Dispute this row |
| Nuveen, LLC Partly reported under another manager | 115,361 SH | 558,348 dollars | Higher by 44,018 Prior quarter: 71,343 | Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row |
| BANK OF AMERICA CORP /DE/ Partly reported under another manager | 108,949 SH | 527,313 dollars | Higher by 53,944 Prior quarter: 55,005 | Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row |
| SEI INVESTMENTS CO Partly reported under another manager | 105,414 SH | 510,204 dollars | Not in the prior quarter’s filings read | Open filing 0000350894-26-000059 Filed 2026-11-10 Dispute this row |
| Stonepine Capital Management, LLC | 98,147 SH | 475,031 dollars | Lower by 2,571 Prior quarter: 100,718 | Open filing 0001440771-26-000027 Filed 2026-11-13 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- SummitTX Capital, L.P. 1,007,351 SH
- JANE STREET GROUP, LLC 188,988 SH
- Sixth Street Partners Management Company, L.P. 165,053 SH
- Mink Brook Asset Management LLC 161,205 SH
- Jump Financial, LLC 94,820 SH
- EntryPoint Capital, LLC 50,883 SH
- Empowered Funds, LLC 42,065 SH
- BRIDGEWAY CAPITAL MANAGEMENT, LLC 42,065 SH
- MANGROVE PARTNERS IM, LLC 41,717 SH
- Point72 Asset Management, L.P. 18,922 SH
- KESTRA PRIVATE WEALTH SERVICES, LLC 12,800 SH
- STONERIDGE INVESTMENT PARTNERS LLC 12,695 SH
- Engineers Gate Manager LP 12,063 SH
- INTECH INVESTMENT MANAGEMENT LLC 11,566 SH
- STRS OHIO 10,500 SH
- TD Waterhouse Canada Inc. 3,000 SH
- GGM Financial LLC 1,005 SH
- INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 521 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text; they are read only when their rows add up to the totals the filer states.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Institutional ownership reported on Form 13F
13F filers report holding between 45.64% and 80.54% of shares outstanding.
Quarter ending 2026-09-30, against 96,654,336 shares on the cover dated 2026-11-06.
- The lower figure counts positions a manager reports as its own with sole discretion. The upper figure counts every plain-share position and can count a share twice.
- Neither includes holders that do not file Form 13F, or managers below the filing threshold.
| Quarter | Managers holding | Shares, at least | Shares, at most | Filings read |
|---|---|---|---|---|
| 2026-09-30 | 114 | 44,114,478 | 77,847,694 | 8,935 |
| 2026-06-30 | 104 | 37,280,493 | 60,803,428 | 9,178 |
| 2026-03-31 | 79 | 30,395,697 | 45,424,231 | 9,173 |
| 2025-12-31 | 59 | 19,609,113 | 27,812,368 | 9,222 |
| 2025-09-30 | 48 | 12,728,720 | 19,036,304 | 8,469 |
| 2025-06-30 | 44 | 11,709,267 | 17,630,451 | 8,516 |
| 2025-03-31 | 47 | 11,166,786 | 14,560,316 | 8,518 |
| 2024-12-31 | 44 | 505,049 | 3,678,876 | 8,580 |
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP Common Stock, par value $0.0001 per share | 6.61 | 5,500,000.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001172661-26-005298 Dispute this row |
| Bihua Chen Common Stock, par value $0.0001 per share | 6.61 | 5,500,000.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001172661-26-005298 Dispute this row |
| Caligan Partners LP Common Stock, $0.0001 par value per share | 6.2 | 5,960,972.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001727492-26-000027 Dispute this row |
| JOHNSON DAVID EDWARD Common Stock, $0.0001 par value per share | 6.2 | 5,960,972.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001727492-26-000027 Dispute this row |
| BALYASNY ASSET MANAGEMENT L.P. Common Stock | 7.36 | 6,120,982.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001172661-26-005045 Dispute this row |
| BAM GP LLC Common Stock | 7.36 | 6,120,982.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001172661-26-005045 Dispute this row |
| Balyasny Asset Management Holdings LP Common Stock | 7.36 | 6,120,982.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001172661-26-005045 Dispute this row |
| Dames GP LLC Common Stock | 7.36 | 6,120,982.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001172661-26-005045 Dispute this row |
| Dmitry Balyasny Common Stock | 7.36 | 6,120,982.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001172661-26-005045 Dispute this row |
| Perceptive Advisors LLC Common Stock, $0.0001 par value per share | 9.99 | 10,086,525 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001193125-26-463810 Dispute this row |
| Joseph Edelman Common Stock, $0.0001 par value per share | 9.99 | 10,086,525 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001193125-26-463810 Dispute this row |
| Perceptive Life Sciences Master Fund, Ltd. Common Stock, $0.0001 par value per share | 9.99 | 10,086,525 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001193125-26-463810 Dispute this row |
| Boxer Capital Management, LLC Common Stock, $0.0001 par value per share | 5.4 | 4,533,660.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001213900-26-120703 Dispute this row |
| Boxer Holdings, LP Common Stock, $0.0001 par value per share | 5.4 | 4,533,660.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001213900-26-120703 Dispute this row |
| Boxer Holdings GP, LLC Common Stock, $0.0001 par value per share | 5.4 | 4,533,660.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001213900-26-120703 Dispute this row |
| Aaron Davis Common Stock, $0.0001 par value per share | 5.4 | 4,533,660.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001213900-26-120703 Dispute this row |
| Adage Capital Management, L.P. Common Stock, par value $0.0001 per share | 2.71 | 2,254,996.00 | 09/30/2026 Filed 2026-11-12 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-007560 Dispute this row |
| Robert Atchinson Common Stock, par value $0.0001 per share | 2.71 | 2,254,996.00 | 09/30/2026 Filed 2026-11-12 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-007560 Dispute this row |
| Phillip Gross Common Stock, par value $0.0001 per share | 2.71 | 2,254,996.00 | 09/30/2026 Filed 2026-11-12 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-007560 Dispute this row |
| BlackRock, Inc. Common Stock | 6.1 | 5,044,847 | 09/30/2026 Filed 2026-10-27 | SCHEDULE 13G | Open filing 0002012383-26-003823 Dispute this row |
| Perceptive Advisors LLC Common Stock, $0.0001 par value per share | 9.99 | 9,233,710 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-26-352641 Dispute this row |
| Joseph Edelman Common Stock, $0.0001 par value per share | 9.99 | 9,233,710 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-26-352641 Dispute this row |
| Perceptive Life Sciences Master Fund, Ltd. Common Stock, $0.0001 par value per share | 9.99 | 9,233,710 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-26-352641 Dispute this row |
| BALYASNY ASSET MANAGEMENT L.P. Common Stock | 6.64 | 5,480,210.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001172661-26-003425 Dispute this row |
| BAM GP LLC Common Stock | 6.64 | 5,480,210.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001172661-26-003425 Dispute this row |
| Balyasny Asset Management Holdings LP Common Stock | 6.64 | 5,480,210.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001172661-26-003425 Dispute this row |
| Dames GP LLC Common Stock | 6.64 | 5,480,210.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001172661-26-003425 Dispute this row |
| Dmitry Balyasny Common Stock | 6.64 | 5,480,210.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001172661-26-003425 Dispute this row |
| Caligan Partners LP Common Stock, $0.0001 par value per share | 7.3 | 6,077,084.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001727492-26-000020 Dispute this row |
| JOHNSON DAVID EDWARD Common Stock, $0.0001 par value per share | 7.3 | 6,077,084.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001727492-26-000020 Dispute this row |
| Foundation Fighting Blindness Retinal Degeneration Fund Common Stock, $0.0001 par value per share | 4.66 | 3,792,171 | 05/18/2026 Filed 2026-05-20 | SCHEDULE 13D/AAmendment 3 | Open filing 0001193125-26-233062 Dispute this row |
| Foundation Fighting Blindness, Inc. Common Stock, $0.0001 par value per share | 4.66 | 3,792,171 | 05/18/2026 Filed 2026-05-20 | SCHEDULE 13D/AAmendment 3 | Open filing 0001193125-26-233062 Dispute this row |
| AARON G.L. FLETCHER Common Stock, $0.0001 par value per share | 4.53 | 3,683,429 | 05/12/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0001791917-26-000005 Dispute this row |
| BIOS ADVISORS GP, LLC Common Stock, $0.0001 par value per share | 4.53 | 3,683,429 | 05/12/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0001791917-26-000005 Dispute this row |
| BIOS CAPITAL MANAGEMENT, LP Common Stock, $0.0001 par value per share | 4.53 | 3,683,429 | 05/12/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0001791917-26-000005 Dispute this row |
| BIOS EQUITY PARTNERS III, LP Common Stock, $0.0001 par value per share | 4.53 | 3,683,429 | 05/12/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0001791917-26-000005 Dispute this row |
| BIOS FUND III, LP Common Stock, $0.0001 par value per share | 0.53 | 430,665 | 05/12/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0001791917-26-000005 Dispute this row |
| BIOS FUND III NT, LP Common Stock, $0.0001 par value per share | 0.55 | 450,811 | 05/12/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0001791917-26-000005 Dispute this row |
| BIOS FUND III QP, LP Common Stock, $0.0001 par value per share | 3.44 | 2,801,953 | 05/12/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0001791917-26-000005 Dispute this row |
| CAVU ADVISORS, LLC Common Stock, $0.0001 par value per share | 4.53 | 3,683,429 | 05/12/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0001791917-26-000005 Dispute this row |
| CAVU MANAGEMENT, LP Common Stock, $0.0001 par value per share | 4.53 | 3,683,429 | 05/12/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0001791917-26-000005 Dispute this row |
| LESLIE W. KREIS Common Stock, $0.0001 par value per share | 4.53 | 3,683,429 | 05/12/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0001791917-26-000005 Dispute this row |
| Perceptive Advisors LLC Common Stock, $0.0001 par value per share | 9.99 | 8,830,145 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-226555 Dispute this row |
| Joseph Edelman Common Stock, $0.0001 par value per share | 9.99 | 8,830,145 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-226555 Dispute this row |
| Perceptive Life Sciences Master Fund, Ltd. Common Stock, $0.0001 par value per share | 9.99 | 8,830,145 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-226555 Dispute this row |
| Caligan Partners LP Common Stock, $0.0001 par value per share | 8.5 | 6,075,028.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G | Open filing 0001727492-26-000010 Dispute this row |
| JOHNSON DAVID EDWARD Common Stock, $0.0001 par value per share | 8.5 | 6,075,028.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G | Open filing 0001727492-26-000010 Dispute this row |
| Nantahala Capital Management, LLC Common Stock, $0.0001 par value per share | 6.51 | 4,839,225.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0001104659-26-062694 Dispute this row |
| Wilmot B. Harkey Common Stock, $0.0001 par value per share | 6.51 | 4,839,225.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0001104659-26-062694 Dispute this row |
| Daniel Mack Common Stock, $0.0001 par value per share | 6.51 | 4,839,225.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0001104659-26-062694 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
3,104,499 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 258,595 |
| 2016 | 246,472 |
| 2017 | 244,814 |
| 2018 | 245,575 |
| 2019 | 238,619 |
| 2020 | 249,093 |
| 2021 | 274,850 |
| 2022 | 257,922 |
| 2023 | 253,676 |
| 2024 | 261,106 |
| 2025 | 235,525 |
| 2026 | 263,830 |
Filings made before the SEC required XML are listed, not extracted.